Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-hydroxy-2-methylquinazolin-4(3H)-one is a quinazolinone derivative, a class of chemical compounds with potential biological activities. It is a white to off-white crystalline powder with a molecular structure that includes a quinazoline ring, a hydroxyl group, and a methyl group. 3-hydroxy-2-methylquinazolin-4(3H)-one has a molecular weight of 179.18 g/mol and is widely used in pharmaceutical research and development due to its antiviral, anticancer, and anti-inflammatory properties, making it a promising target for drug discovery and development.

1010-70-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1010-70-4 Structure
  • Basic information

    1. Product Name: 3-hydroxy-2-methylquinazolin-4(3H)-one
    2. Synonyms: 4(3H)-quinazolinone, 3-hydroxy-2-methyl-
    3. CAS NO:1010-70-4
    4. Molecular Formula: C9H8N2O2
    5. Molecular Weight: 176.172
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1010-70-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 364.6°C at 760 mmHg
    3. Flash Point: 174.3°C
    4. Appearance: N/A
    5. Density: 1.35g/cm3
    6. Vapor Pressure: 5.91E-06mmHg at 25°C
    7. Refractive Index: 1.653
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 3-hydroxy-2-methylquinazolin-4(3H)-one(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-hydroxy-2-methylquinazolin-4(3H)-one(1010-70-4)
    12. EPA Substance Registry System: 3-hydroxy-2-methylquinazolin-4(3H)-one(1010-70-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1010-70-4(Hazardous Substances Data)

1010-70-4 Usage

Uses

Used in Pharmaceutical Research and Development:
3-hydroxy-2-methylquinazolin-4(3H)-one is used as a target compound for drug discovery and development due to its potential biological activities, including antiviral, anticancer, and anti-inflammatory properties. Its molecular structure serves as a basis for the design of new drugs with improved bioactivity and pharmacological properties.
Used in Antiviral Applications:
3-hydroxy-2-methylquinazolin-4(3H)-one is used as an antiviral agent, exhibiting potential activity against various viral infections. Its antiviral properties make it a valuable compound for the development of new antiviral drugs.
Used in Anticancer Applications:
3-hydroxy-2-methylquinazolin-4(3H)-one is used as an anticancer agent, showing potential in inhibiting the growth and proliferation of cancer cells. Its anticancer properties make it a promising candidate for the development of novel cancer therapeutics.
Used in Anti-inflammatory Applications:
3-hydroxy-2-methylquinazolin-4(3H)-one is used as an anti-inflammatory agent, demonstrating potential in reducing inflammation and alleviating symptoms associated with inflammatory conditions. Its anti-inflammatory properties make it a valuable compound for the development of new anti-inflammatory drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 1010-70-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,1 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1010-70:
(6*1)+(5*0)+(4*1)+(3*0)+(2*7)+(1*0)=24
24 % 10 = 4
So 1010-70-4 is a valid CAS Registry Number.

1010-70-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-hydroxy-2-methylquinazolin-4-one

1.2 Other means of identification

Product number -
Other names 3-hydroxy-2-methylquinazolin-4(3H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1010-70-4 SDS

1010-70-4Relevant articles and documents

Synthesis and application of N-hydroxylamine derivatives as potential replacements for HOBt

El-Faham, Ayman,Albericio, Fernando

, p. 1499 - 1501 (2009)

Several heterocycles containing N-hydroxylamine were prepared and tested as coupling additives to replace the use of N-hydroxybenzolriazole (HOBt.) derivatives. On the basis of our results on coupling yield and racemization-suppressing properties, we propose N-hydroxyindolin-2-one and 6- cfiloro-N-hydroxy-2-phenylbenzimidazole as suitable substitutes for HOBt. Wiley-VCH Verlag GmbH & Co. KGaA.

Metal complexes of cyclic hydroxamates. Synthesis and crystal structures of 3-hydroxy-2-methyl-3H-quinazolin-4-one (ChaH) and of its Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes

Alagha, Ahmed,Parthasarathi, Laavanya,Gaynor, Declan,Müller-Bunz, Helge,Starikova, Zoya A.,Farkas, Etelka,O'Brien, Eimear C.,Gil, Marie-Jose,Nolan, Kevin B.

, p. 58 - 66 (2011)

The attempted acetylation of anthranilic hydroxamic acid (2-aminobenzohydroxamic acid) as a possible dual inhibitor of the catalytic sites in prostaglandin-H-synthase (PGHS) gave the cyclic hydroxamic acid 3-hydroxy-2-methyl-3H-quinazolin-4-one (ChaH) which was characterised by spectroscopy and X-ray crystallography. The length of the hydroxamic acid C-N bond, 1.3998(17) ?, in ChaH is longer than normal (~1.33 ?) indicative of reduced delocalisation of the nitrogen lone pair of electrons into the hydroxamic acid π system. This is confirmed by the appearance of the ν(CO) band at a considerably higher wavenumber in the IR spectrum than normal. The complexes Fe(Cha)2(Cl)(H2O) ·7/2H2O, Co(Cha)2(EtOH) 2, Ni(Cha)2(EtOH)2, Cu(Cha)(H2O)(Cl) and Zn(Cha)2(H2O), have been synthesised and their structures determined by X-ray crystallography. The X-ray data confirmed coordination by Cha- through the carbonyl and deprotonated hydroxamate oxygen in all cases. The M-O (hydroxamate) bonds are shorter than the M-O (carbonyl) bonds by between 0.0930 ? for the Co(II) complex and 0.0448 ? for the Ni(II) complex. The geometries of all complexes conform to the coordination requirements of the particular metal ion involved. Speciation studies for ChaH and its complexes with Ni(II) and Zn(II) were carried out using pH-metric methods. The results show that ChaH is much more acidic than related acyclic hydroxamic acids and that its metal complexes are correspondingly less stable.

PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS

-

, (2010/06/19)

Novel iminium-type coupling agents containing proton acceptors in their iminium moiety, which can be used beneficially as coupling agents in various chemical polypeptide and/or polynucleotide syntheses, and are particularly useful as yield enhancing and racemization suppressing coupling agents for use in peptide syntheses, are disclosed. Further disclosed are a process of preparing such iminium-type coupling agents and their use in the preparation of polypeptides and/or polynucleotides.

Fragment-based lead discovery: Screening and optimizing fragments for thermolysin inhibition

Englert, Lisa,Silber, Katrin,Steuber, Holger,Brass, Sascha,Over, Bjoern,Gerber, Hans-Dieter,Heine, Andreas,Diederich, Wibke E.,Klebe, Gerhard

experimental part, p. 930 - 940 (2011/02/24)

Fragment-based drug discovery has gained a foothold in today's lead identification processes. We present the application of in silico fragment-based screening for the discovery of novel lead compounds for the metalloendoproteinase thermolysin. We have chosen thermolysin to validate our screening approach as it is a well-studied enzyme and serves as a model system for other proteases. A protein-targeted virtual library was designed and screening was carried out using the program AutoDock. Two fragment hits could be identified. For one of them, the crystal structure in complex with thermolysin is presented. This compound was selected for structure-based optimization of binding affinity and improvement of ligand efficiency, while concomitantly keeping the fragment-like properties of the initial hit. Redesigning the zinc coordination group revealed a novel class of fragments possessing Ki values as low as 128 μm, thus they provide a good starting point for further hit evolution in a tailored lead design.

Synthesis of new fused hetecrocyclic compounds of benzpyrid-4-one derivatives and their some biological activity

Soleiman,Koraiem,Mahmoud

, p. 553 - 560 (2007/10/03)

A series of fused pyrazolino-, Isoxazolino-, Pyrimidino-, Pyrimidinothino-, thiazolidinones and β-lactam incorporating benzpyrid-4-one derivatives have been synthesized by different methods of chemical reaction. The prepared compounds were established by universals and modern methods of physical and chemical confirmation.

Reactions of 3-hydroxy-1,2-dihydroquinazolin-4-ones with acid chlorides

Luk'yanov,Gordeev

, p. 1335 - 1338 (2007/10/03)

The reactions of 3-hydroxy-1,2-dihydroquinazolin-4-ones with acid chlorides can afford compounds of different types. The structures of the products depend on the type of acid chloride used and on the nature of the substituent at position 2 of the 3-hydroxy-1,2-dihydroquinazolin-4-one.

Unexpected formation of cyclic hydroxamic acids from O-(2-aminobenzoyl) hydroxylamine

Sahadeva Reddy,Shailaja,Pratap Reddy,Reddy

, p. 2843 - 2846 (2007/10/03)

Cyclic hydroxamic acids 3 and 4 are the unexpected products in the reaction of O-(2-aminobenzoyl) hydroxylamine 1 and orthoesters, acid chlorides, ethyl chloroformate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1010-70-4